Does Rallies show Form 4 insider transactions for NEPH?

Yes. Rallies tracks NEPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is NEPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NEPH. It does not provide personalized investment advice.

NEPH (Nephros Inc.) Stock Analysis - Insider Trades

Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of May 21, 2026, NEPH trades at $3.57 with a market cap of $39.95M and a P/E ratio of 32.64. NEPH moved -2.34% today. Year to date, NEPH is -26.65%; over the trailing twelve months it is +54.68%. Its 52-week range spans $1.36 to $6.42. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading NEPH stock inside the company?

Recent NEPH insider activity includes Amron Arthur H bought 3.00K, Amron Arthur H bought 2.00K, Banks Robert R. Jr. bought 50.00K, Amron Arthur H bought 7.00K, and Banks Robert R. Jr. bought 18.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

NEPH Key Metrics

Key financial metrics for NEPH
Metric	Value
Price	$3.57
Market Cap	$39.95M
P/E Ratio	32.64
EPS	$0.11
Dividend Yield	0.00%
52-Week High	$6.42
52-Week Low	$1.36
Volume	0
Avg Volume	0
Revenue (TTM)	$18.79M
Net Income	$1.19M
Gross Margin	61.87%

Recent NEPH Insider Trades

Amron Arthur H bought 3.00K (~$6.73K) on May 30, 2024.
Amron Arthur H bought 2.00K (~$4.44K) on May 28, 2024.
Banks Robert R. Jr. bought 50.00K (~$112.05K) on May 16, 2024.
Amron Arthur H bought 7.00K (~$17.13K) on Mar 12, 2024.
Banks Robert R. Jr. bought 18.00K (~$39.65K) on Dec 7, 2023.

Latest NEPH News

Nephros Targets $25M New York Market with New Regional Sales Leader — Apr 16, 2026
Nephros Launches Chargeable Water Management Programs After ASSE 12080 Certification — Apr 1, 2026
Nephros Q4 Net Income Drops 67% as Gross Margin Falls to 58% — Mar 14, 2026

NEPH Analyst Consensus

1 analysts cover NEPH: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.

Common questions about NEPH

Who is trading NEPH stock inside the company?: Recent NEPH insider activity includes Amron Arthur H bought 3.00K, Amron Arthur H bought 2.00K, Banks Robert R. Jr. bought 50.00K, Amron Arthur H bought 7.00K, and Banks Robert R. Jr. bought 18.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for NEPH?: Yes. Rallies tracks NEPH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NEPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NEPH. It does not provide personalized investment advice.